Correlation Between Antisense Therapeutics and US Lithium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Antisense Therapeutics and US Lithium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antisense Therapeutics and US Lithium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antisense Therapeutics Limited and US Lithium Corp, you can compare the effects of market volatilities on Antisense Therapeutics and US Lithium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antisense Therapeutics with a short position of US Lithium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antisense Therapeutics and US Lithium.

Diversification Opportunities for Antisense Therapeutics and US Lithium

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Antisense and LITH is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Antisense Therapeutics Limited and US Lithium Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US Lithium Corp and Antisense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antisense Therapeutics Limited are associated (or correlated) with US Lithium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US Lithium Corp has no effect on the direction of Antisense Therapeutics i.e., Antisense Therapeutics and US Lithium go up and down completely randomly.

Pair Corralation between Antisense Therapeutics and US Lithium

Assuming the 90 days horizon Antisense Therapeutics Limited is expected to generate 6.0 times more return on investment than US Lithium. However, Antisense Therapeutics is 6.0 times more volatile than US Lithium Corp. It trades about 0.07 of its potential returns per unit of risk. US Lithium Corp is currently generating about -0.06 per unit of risk. If you would invest  1.00  in Antisense Therapeutics Limited on November 3, 2024 and sell it today you would lose (0.82) from holding Antisense Therapeutics Limited or give up 82.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.76%
ValuesDaily Returns

Antisense Therapeutics Limited  vs.  US Lithium Corp

 Performance 
       Timeline  
Antisense Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Antisense Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward-looking indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
US Lithium Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US Lithium Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Antisense Therapeutics and US Lithium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Antisense Therapeutics and US Lithium

The main advantage of trading using opposite Antisense Therapeutics and US Lithium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antisense Therapeutics position performs unexpectedly, US Lithium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Lithium will offset losses from the drop in US Lithium's long position.
The idea behind Antisense Therapeutics Limited and US Lithium Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume